Your browser doesn't support javascript.
loading
Evaluation of Pharmacia CAP System FEIA for House Dust Mites in Patients with Atopic Dermatitis / 대한피부과학회지
Korean Journal of Dermatology ; : 1455-1462, 2003.
Article in Korean | WPRIM (Western Pacific) | ID: wpr-108214
Responsible library: WPRO
ABSTRACT

BACKGROUND:

Specific serum IgE determination is widely used in the diagnosis of IgE-mediated allergic diseases. House dust mite allergens are known to show good sensitivity on in vitro tests. We report the results of specific IgE against house dust allergen by Pharmacia CAP system FEIA and compared them with those of in vivo test.

OBJECTIVE:

The aim of this study is to find out the clinical application of Pharmacia CAP system FEIA in atopic dermatitis.

METHODS:

In 46 atopic dermatitis patients, skin prick test and Pharmacia CAP system FEIA were performed for Dermatophagoides pteronyssinus and Dermatophagoides farinae allergens. For all patients, atopy and family histories were taken.

RESULTS:

The positive results were more frequent in adult patients(over 16 years old, 73.3%) than in child patients(below 15 years old, 38.7%) in skin prick test for both Dermatophagoides pteronyssinus and Dermatophagoides farinae allergens. When skin prick tests were used as a reference standard, the sensitivity of Pharmacia CAP system FEIA was 89.5% for Dermatophagoides pteronyssinus and 90.0% for Dermatophagoides farinae, and the specificity of Pharmacia CAP system FEIA was 77.8% for Dermatophagoides pteronyssinus and 80.8% for Dermatophagoides farinae. Correlations were found between Pharmacia CAP system FEIA results and serum total IgE (r=0.574 for Dermatophagoides pteronyssinus and r=0.534 for Dermatophagoides farinae).

CONCLUSION:

Our results suggest that Pharmacia CAP system FEIA offers high sensitivity and can be an effective method of screening for allergies to Dermatophagoides pteronyssinus and Dermatophagoides farinae in atopic dermatitis.
Subject(s)

Full text: Available Health context: SDG3 - Health and Well-Being / SDG3 - Target 3.4 Reduce premature mortality due to noncommunicable diseases Health problem: Target 3.2: Reduce avoidable death in newborns and children under 5 / Skin Diseases Database: WPRIM (Western Pacific) Main subject: Skin / Immunoglobulin E / Allergens / Mass Screening / Sensitivity and Specificity / Pyroglyphidae / Dermatophagoides farinae / Dermatophagoides pteronyssinus / Antigens, Dermatophagoides / Dermatitis, Atopic Type of study: Diagnostic study / Screening study Limits: Adolescent / Adult / Child / Humans Language: Korean Journal: Korean Journal of Dermatology Year: 2003 Document type: Article
Full text: Available Health context: SDG3 - Health and Well-Being / SDG3 - Target 3.4 Reduce premature mortality due to noncommunicable diseases Health problem: Target 3.2: Reduce avoidable death in newborns and children under 5 / Skin Diseases Database: WPRIM (Western Pacific) Main subject: Skin / Immunoglobulin E / Allergens / Mass Screening / Sensitivity and Specificity / Pyroglyphidae / Dermatophagoides farinae / Dermatophagoides pteronyssinus / Antigens, Dermatophagoides / Dermatitis, Atopic Type of study: Diagnostic study / Screening study Limits: Adolescent / Adult / Child / Humans Language: Korean Journal: Korean Journal of Dermatology Year: 2003 Document type: Article
...